These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2322338)

  • 21. A multiplex ARMS test for 10 cystic fibrosis (CF) mutations: evaluation in a prenatal CF screening program.
    Bradley LA; Johnson DA; Chaparro CA; Robertson NH; Ferrie RM
    Genet Test; 1998; 2(4):337-41. PubMed ID: 10464613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystic fibrosis. Part II. New developments in cystic fibrosis--implications for carrier detection and genetic counselling.
    Denter M; Ramsay M; Jenkins T
    S Afr Med J; 1992 Jul; 82(1):11-3. PubMed ID: 1641710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on population-based preconception and prenatal cystic fibrosis carrier screening.
    Nolen AA; Rhoades ED
    J Okla State Med Assoc; 2003 Oct; 96(10):482-4. PubMed ID: 14619603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrier screening in CF.
    ten Kate LP
    Nature; 1989 Nov; 342(6246):131. PubMed ID: 2812012
    [No Abstract]   [Full Text] [Related]  

  • 25. Association between carrier screening and incidence of cystic fibrosis.
    Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM
    JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic fibrosis screening strategies.
    Cuckle H
    Br J Hosp Med; 1993 Oct 6-19; 50(7):398-402. PubMed ID: 8261285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 10-year large-scale cystic fibrosis carrier screening in the Italian population.
    Picci L; Cameran M; Marangon O; Marzenta D; Ferrari S; Frigo AC; Scarpa M
    J Cyst Fibros; 2010 Jan; 9(1):29-35. PubMed ID: 19897426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis.
    Lemna WK; Feldman GL; Kerem B; Fernbach SD; Zevkovich EP; O'Brien WE; Riordan JR; Collins FS; Tsui LC; Beaudet AL
    N Engl J Med; 1990 Feb; 322(5):291-6. PubMed ID: 2296270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
    Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygote screening for cystic fibrosis.
    Brock DJ
    J Med Screen; 1994 Apr; 1(2):130-3; discussion 133-4. PubMed ID: 8790502
    [No Abstract]   [Full Text] [Related]  

  • 31. A comprehensive screening program for cystic fibrosis.
    Zlotogora J; Israeli A
    Isr Med Assoc J; 2009 Sep; 11(9):555-7. PubMed ID: 19960851
    [No Abstract]   [Full Text] [Related]  

  • 32. Human Genetics Society of Australasia position statement: population-based carrier screening for cystic fibrosis.
    Delatycki MB; Burke J; Christie L; Collins F; Gabbett M; George P; Haan E; Ioannou L; Martin N; McKenzie F; O'Leary P; Scoble-Williams N; Turner G; Massie J;
    Twin Res Hum Genet; 2014 Dec; 17(6):578-83. PubMed ID: 25431289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New possibilities for population control of cystic fibrosis.
    Dodge JA; Boulyjenkov V
    Bull World Health Organ; 1992; 70(5):561-6. PubMed ID: 1464143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of population screening for carriers of cystic fibrosis.
    Smith MJ
    J Public Health Med; 1992 Sep; 14(3):257-63. PubMed ID: 1419203
    [No Abstract]   [Full Text] [Related]  

  • 35. The views of general practitioners on community carrier screening for cystic fibrosis.
    Boulton M; Cummings C; Williamson R
    Br J Gen Pract; 1996 May; 46(406):299-301. PubMed ID: 8762747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening.
    Cunningham F; Lewis S; Curnow L; Glazner J; Massie J
    J Cyst Fibros; 2014 Jan; 13(1):99-105. PubMed ID: 23891279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; OĊ‚tarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The D1152H cystic fibrosis mutation in prenatal carrier screening, patients and prenatal diagnosis.
    Peleg L; Karpati M; Bronstein S; Berkenstadt M; Frydman M; Yonath H; Pras E
    J Med Screen; 2011; 18(4):169-72. PubMed ID: 22156145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Towards an improved antenatal screening for cystic fibrosis].
    Serre JL; Feingold J; Simon-Bouy B; Muller F
    Rev Epidemiol Sante Publique; 2003 Apr; 51(2):245-53. PubMed ID: 12876510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing: CF screening premature?
    McGourty C
    Nature; 1989 Nov; 342(6248):334. PubMed ID: 2586598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.